FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Angel One, BP Equities (BP Wealth), GEPL Capital Ltd, Hem Securities and Motilal Oswal have given "Apply" recommendation to Anupam Rasayan IPO. Canara Bank, Choice Equity Broking Pvt Ltd, Dilip Davda and Investmentz Ltd have given "May Apply" recommendation to Anupam Rasayan IPO. Capital Market recommend to "Avoid" the IPO.Ashika Research, Axis Capital, ICICI Direct and Reliance Securities have "Not Rated" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 5 | 4 | 0 | 1 | 4 |
% | 35.71 | 28.57 | 0.00 | 7.14 | 28.57 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Angel One | Apply | |
Ashika Research | Not Rated | |
Axis Capital | Not Rated | |
BP Equities (BP Wealth) | Apply | |
Canara Bank | May Apply | |
Capital Market | Avoid | |
Choice Equity Broking Pvt Ltd | May Apply | |
Dilip Davda | May Apply | |
GEPL Capital Ltd | Apply | |
Hem Securities | Apply | |
ICICI Direct | Not Rated | |
Investmentz Ltd | May Apply | |
Motilal Oswal | Apply | |
Reliance Securities | Not Rated |
The Captial Market (CapitalMarket.com) rating for Anupam Rasayan IPO is 42. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 42 | Avoid, however active risk seekers can try |
[Dilip Davda] Based on the companyââ‚-â„¢s financial data, the issue appears aggressively priced. However, considering the rising fancy for life care and speciality chemicals segment linked with future performance trends, the company is expected to do well post listing going forward. Based on these aspects, investors looking for a long term bet may consider investing in this IPO. Read detail review...
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|